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Abstract
Background: Areca nut is the seed of fruit oriental palm known as Areca catechu. Many adverse effects of nut
chewing have been well documented in the medical literature. As these nuts are mixed with some other
substances like tobacco and flavouring agents, it has been hypothesized that it might also cause some
dependency symptoms among its users. Therefore, the objective of this study was to investigate dependency
syndrome among areca nut users with and without tobacco additives and compare it with dependency associated
with cigarette smoking among the male Pakistani population.
Methods: This was an observational cross sectional study carried out on healthy individuals, who were users of
any one of the three products (areca nut only, areca nut with tobacco additives, cigarette smokers). Participants
were selected by convenience sampling of people coming to hospital to seek a free oral check up. Information
was collected about the socio-demographic profile, pattern of use and symptoms of dependency using the DSM-IV
criteria for substance dependence. We carried out multiple logistic regressions to investigate association between
socio-demographic profile, pattern of substance use and dependency syndrome.
Results: We carried out final analysis on 851 individuals, of which 36.8% (n = 314) were areca nut users, 28.4% (n =
242) were the chewers of areca with tobacco additives and 34.7% (n = 295) were regular cigarette smokers.
Multivariate analyses showed that individuals using areca nut with tobacco additives were significantly more likely
to have dependency syndrome (OR = 2.17, 95% CI 1.39-3.40) while cigarette smokers were eight times more likely
to have dependency syndrome as compared to areca nut only users.
Conclusions: Areca nut use with and without tobacco additives was significantly associated with dependency
syndrome. In comparison to exclusive areca nut users, the smokers were eight times more likely to develop
dependence while areca nut users with tobacco additives were also significantly more likely to suffer from the
dependence.
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Background
Areca nut is the seed of the fruit of the tropical palm
tree, Areca Catechu. This tree bears fruit throughout
the year and areca nut is obtained from it, which is a
basic ingredient of widely used chewing products[1].
Thin slices of nuts either natural or processed are then
mixed with a variety of substances including slaked lime
(calcium hydroxide) and spices such as carda-mom,
coconut, and saffron [2,3]. Most importantly these nuts
are also mixed with some tobacco products.
The areca nut is considered to be the fourth most
commonly used psychoactive substance after the
tobacco, alcohol and caffeine and it has been suggested
that approximately 10% of the World’s population chew
it regularly[4]. The usage of areca nut is indigenous to
India, Sri Lanka, Maldives, Bangladesh, Myanmar, Tai-
wan and numerous islands in South Pacific. It is also
consumed in parts of Thailand, Indonesia, Malaysia,
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Cambodia, Vietnam, Philippines, Laos, and China and in
the migrant individuals from these countries [5,6].
Among the populations residing in South and East Asia,
areca nut chewing is socially acceptable. The epidemio-
logical data pertaining to areca nut use in Pakistan has
been reported in different subgroups and rates vary
depending on the sample studied and the geographical
area in which the study was conducted [3,6,7]. However
nut chewing is a common practice which usually starts
in school life and remains prevalent till adulthood.
Many epidemiological studies have revealed that con-
tinuous use of areca nut is associated with many adverse
health effects from oral leukoplakia to submucous fibro-
sis which is subsequently linked with cancer risk [4,5,8].
WHO International Agency for Research on Cancer
Monograph Working Group (2009) highlighed that the
evidence on areca nut and its assosciation with oral,
pharyngeal and esophageal cancer is sufficient to estab-
lish a causal link[8].
Areca nut chewing has been claimed to manifest a
sense of well-being, euphoria, salivation, warm sensation
of the body, low to moderate sweating and palpitations
[9]. These characteristics of areca nut along with its
ingredients highlight the existence of some dependency
symptoms among its users.
Small scale observational studies have reported the
existence of dependency syndrome among the users of
areca products [10,11]. A relatively larger study, which
was conducted in India reported that areca nut use
alone and more so with tobacco additives, is associated
with the development of a dependency syndrome among
significantly larger proportions of its users i.e. 39% and
79% respectively [9]. However little is confirmed about
the dependency syndrome among areca nut users as
compared to the symptoms of dependency among
tobacco users (cigarette smokers).
Previous evidence highlights the need to investigate
this condition among areca nut users, with and without
tobacco additives, and tobacco users. Therefore, the pre-
sent study was carried out to explore the dependency
syndrome among the areca nut chewers in comparison
with cigarette smokers. Furthermore, the study also has
an objective to investigate the major determinants asso-
ciated with the dependency syndrome among the areca
nut chewers and cigarette smokers.
Methods
We included healthy individuals from population for
this study who were invited to outdoor patients depart-
ment of Civil Hospital Karachi. The participants were
provided a free oral check-up with an oral surgeon at
this site. We only included those individuals in this
study who were users of any one of the three products
(i.e. Areca nut only or Areca nut with tobacco additives
or just tobacco use in the form of cigarettes). We pre-
pared a list of 50 areca nut products commonly available
in market, so that individuals can be classified in groups
accurately. This study was approved from the hospital
authorities and an independent ethical committee
reviewed and approved the study protocol.
Inclusion criteria
All willing healthy male individuals between the ages of
16 to 35 who visited the outdoor patient department
during January 2009 to December 2010 in response to
the invitation were included in this study.
Exclusion criteria
Individuals who refused to participate in the survey or
were unable to understand Urdu (National language of
Pakistan) were excluded from this survey. Individuals
who visited the hospital due to current illness or follow
up of a previous illness were also excluded.
Instrument
Information was collected by using a pre-tested ques-
tionnaire, which contained the information about socio-
demographic profile (including age, years of education,
nature of job/study), pattern of substance use (fre-
quency, number of years since use, daily consumption,
type of substance and family history of use). A single
page information sheet was designed to convey the aim
and objectives of the study to the participants and verbal
consent was obtained prior to employing the
questionnaire.
Questions to determine the presence of substance
dependence, we used The Diagnostic and Statistical
Manual of Mental Disorders (DSM-IV) module for sub-
stance dependence. We translated the DSM-IV module
of substance dependence to Urdu by using a committee
approach. Six individuals participated in this committee
who were bilingual and selected for their proficiency in
both English and Urdu. Two of them translated the
English questionnaire to Urdu at an initial stage, while
another two judged the translation in relation to the ori-
ginal questionnaire. Then on second step the other two
individual who had no prior knowledge about this
DSM-IV module translated the Urdu version back to
English. The two judges again compared the converted
English version of questionnaire to original question-
naire and then all six members sat together to select the
best translations which represents the original. This
questionnaire along with the questionnaire related to
demographics and substance abuse, were piloted to the
first 25 participants of the study. Participants were
asked about any difficulty in understanding and compre-
hension of questions. After assessing the validity, based
on piloted questionnaire we then administered both
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questionnaires to the study participants. Questions were
about the (1)tolerance (needing more to become intoxi-
cated or discovering less effect with same amount) (2)
withdrawal (characteristic withdrawal associated with
this type of drug) (3)Using more or for longer periods
than intended? (4) Desire to or unsuccessful efforts to
cut down? (5) Considerable time spent in obtaining the
substance or using, or recovering from its effects? (6)
Important social, work, or recreational activities given
up because of use? (7) Continued use despite knowledge
of problems caused by or aggravated by use. Presence of
any three of these during the same 12 months period
confirmed the presence of dependency syndrome.
Sample size estimation
We estimated the sample size to measure 10% difference
of dependency prevalence (assuming 75% prevalence of
dependency syndrome) between groups at 0.05 signifi-
cance level using two sided comparison and power of
80%. Sample size was computed for both the X2 using
the Yates’ continuity correction and Fisher Exact test. A
sample of 630 participants was the minimum number
required to be accrued to perform this survey.
Data analysis
We used Stata software version 11 (StataCorp, College
Station, TX, USA) to analyze the collected information.
Participants were divided into three groups according to
their substance consumption ("areca nut only”, “areca
with tobacco additives”, “smokers only”). For compari-
son between variables we used, Analysis of Variance
(ANOVA) with bonferroni adjustments for multiple
comparisons of continuous and Kruskal Wallis Test for
ordinal variables. We used multiple logistic regression
using different explanatory variables to assess the asso-
ciation of dependency syndrome with different factors (i.
e. socio-demographic and pattern of substance
consumption).
Results
Basic characteristics of study sample
We collected the information from 900 individuals who
were regular users of any of the three products (i.e.
areca nut or areca with tobacco additives or cigarette
smokers). Data from thirty five subjects lacked basic
information about age, use of product and exact quan-
tity of substance used, while another fourteen subjects
missed some important questions related to dependency
symptoms. Therefore, these forty nine individuals were
excluded from the final analysis. Final analysis was car-
ried out on 851 individuals, out of which 36.8% (n =
314) were areca nut users, 28.4% (n = 242) were the
chewers of areca nut with tobacco additives and 34.7%
(n = 295) were regular smokers. Basic analysis indicated
approximately similar average age in all three groups
(25.5 ± 5.53 vs 25.0 ± 5.62 vs 25.9 ± 5.81: p = 0.19).
There was no significant difference of years of formal
education between the three groups (11.3 ± 2.56 vs 11.8
± 3.26 vs 11.6 ± 2.10). However significant differences
were noted in the family history of substance use and
the number of years since they began using these pro-
ducts (Table 1).
Dependency syndrome among users
The frequency of dependency syndrome between the
three groups was significantly different. Among areca
only users, 67.2% (n = 211) had dependency syndrome
while 78.1% (n = 189) among areca with tobacco addi-
tives users and 89.8% (n = 265) of smokers had depen-
dency syndrome.
When looking at the symptoms of dependence, we
observed significant differences between different groups
of substance users (table 2). Withdrawal symptoms,
attempt to cut down and continue use were significantly
higher among the cigarette smokers (p < 0.001), while
excess use than intended and social or recreational
activity given up were highest among the areca nut only
users (p < 0.001). Excess use among areca users might
be due to tastes of these nuts as different flavouring
agents are added in it.
On univariate analysis, increasing age, family history of
substance use and increasing duration of use were sig-
nificantly associated with increased likelihood of depen-
dency syndrome. Comparison between the groups while
taking the areca only as a reference group showed that
both areca nut with tobacco additives (OR = 1.74, 95%
CI 1.18-2.56) users and smoking only group (OR = 4.31,
95% CI 2.76-6.73) were more likely to have dependency
syndrome (Table 3).
In order to predict the likelihood of existence of
dependency syndrome among the three groups of sub-
stance users a multiple logistic regression was used. We
used the existence of dependency syndrome (on the
basis of DSM-IV criteria) as a dependent variables while
age, years of education, number of years since using,
family history of use and type of substance used as
explanatory variables (independent). Multivariate analy-
sis also showed similar findings as univariate analysis
except that age was no longer associated with depen-
dency syndrome after adjustment for the duration of use
(Table 3). Areca users with tobacco additives were more
likely to have dependency syndrome (OR = 2.17, 95% CI
1.39-3.40) so were the smokers only group (OR = 7.87,
95% CI 4.70-13.15) as compared to areca only users
after adjustments for age, education, family history of
substance use and duration of use (Table 3). We did not
find any significant association between years of full
time education and dependency syndrome.
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Discussion
In this study we observed a trend of dependency syn-
drome between three groups. Nine out of 10 cigarette
smokers had dependency syndrome, while 8 out of 10
areca users with tobacco additives had dependency syn-
drome. As anticipated the frequency of dependency syn-
drome among the areca users with tobacco additives
and cigarette smokers was very high in this sample. This
can be explained by the addictive potential of nicotine.
We observed 78.1% existence of dependency syndrome
among areca users with tobacco additives which is fairly
consistent with a previous study published on Indian
population[9]. Furthermore, we also observed a signifi-
cant difference in existence of dependency syndrome
between areca users with tobacco additives and cigarette
smokers. However it is difficult to exactly differentiate
and estimate the dependency symptom associated with
areca nut or tobacco independently. Dependency syn-
drome among the areca nut only group was 67%,
although high, but have been found slightly inconsistent
in earlier studies as well [9,11] Both of these studies had
smaller sample sizes, so the differences between studies
and in our findings could be simply because of chance.
Another possible explanation is that both studies had
participants from both sexes while we only included
male participants, so observed higher difference in our
study could be because of inclusion of only male indivi-
duals. Previous studies were conducted in England and
India, types of areca nut available in different regions of
the World might explain some of the observed differ-
ences. Biological mechanism underlying the association
of areca nut chewing with dependency syndrome is less
Table 1 Baseline characteristics of sample according to the type of substance used
Type of substance use
Characteristics Number (n) Areca nut only, % Areca + tobacco, % Smokers only, % p value *
Total participants (n) 851 314 (36.8) 242 (28.4) 295 (34.7)
Age at screening (years)
Age 16-20 182 14 22.31 28.47 < 0.001
Age 21-25 311 42 32.64 33.9
Age 26-30 181 28 16.12 18.31
Age 31-35 177 15.9 28.93 19.32
Education (years)
< 10 years 112 7.96 16.94 15.59 < 0.001
10-12 years 490 57.96 39.67 71.86
> 12 years 249 34.08 43.39 12.54
Family history of substance use
Absent 554 55.1 33.06 25.76 < 0.001
Present 297 44.9 66.94 74.24
Duration of use (years)
< 6 years 467 44.59 50 69.83 < 0.001
6-10 years 255 39.49 22.31 26.1
> 10 years 129 15.92 27.69 4.07
* p values were calculated using the chi square test.
Table 2 Dependency symptoms among users of areca nuts, areca nut with tobacco additives and cigarette smokers
Type of substance use
Symptom Areca nut only Areca + Tobacco Smokers only P-value
N = 314 N = 242 N = 295
n (%) n (%) n (%)
Tolerance 101 (32.2) 90 (37.2) 116 (39.3) < 0.001
Withdrawal 87 (27.7) 158 (65.3) 204 (69.2) < 0.001
Excess use 239 (76.1) 102 (42.2) 119 (40.3) < 0.001
Attempt to cut down 93 (29.6) 152 (62.8) 218 (73.9) < 0.001
Considerable time spent before reuse or recovery 88 (28.0) 100 (41.3) 135 (45.8) < 0.001
Activity given up 175 (55.7) 95 (39.3) 65 (22.0) < 0.001
Continue use despite known health hazards 195 (62.1) 138 (57.0) 256 (86.8) < 0.001
p values calculated using the chi2 test between the presence or absence of symptom and group of substances use
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clear, however Arecoline (a psychoactive agent), which is
the main alkaloid of areca nut, has been thoroughly
investigated and areca nut chewing has been suggested
to produce a sense of well being, euphoria, heightened
alertness, sweating, salivation and a hot body sensation
[11]. Combination of these feelings could actually lead
to tolerance from these products and that could ulti-
mately result in the development of dependency
syndrome.
Univariate and multivariate analysis illustrates the level
of dependency syndrome on socio-demographic profile
and pattern of substance use. Increasing age was signifi-
cantly associated with increased likelihood of dependency
syndrome in univariate model but in multivariate model
age was not significantly associated with dependency syn-
drome. The effect of age was found non-significant after
adjustment for the years since substance use began. This
highlights that the longer duration of substance, the
more likely it is to lead to dependency syndrome. Positive
family history of substance usage doubles the likelihood
of developing dependency syndrome compared to those
individuals who did not have the history of substance use
among parents or siblings which is consistent with pre-
vious evidence [12]. Previous evidence showed that
increasing education decreases the likelihood of areca
nut use and dependency, however we did not observe
any association between education and dependency [9].
Smokers were significantly more likely to have depen-
dency syndrome as compared to areca nut only and
areca nut users with tobacco additives, this could be
explained by the effect of nicotine in cigarette and has
been well documented[13,14]. Our analysis illustrated
that smokers were eight times more likely to develop
the syndrome as compare to areca nut users only and
two times more likely to as compared to areca nut users
with tobacco additives. On the basis of our knowledge
this is the first study in South Asian population which
had direct comparison among the three groups of sub-
stance users. We had a reasonably larger sample size to
estimate any difference between the groups.
Limitations of this research
This study has several limitations which need to be
mentioned. As the participants were selected by conve-
nient sampling and from one region of this city, so
given the sample limitations one can not draw conclu-
sions about the population level estimates from this
study. We used only male individuals; therefore, it is dif-
ficult to assume that the frequency of dependency syn-
drome would also be similar among the female
population in this country. Most of the individuals
included in this study were from average or below aver-
age socio-economic class, so the results are not generali-
sable to all the social classes of this country. We used a
Table 3 Univariate and multivariate analyses: factors associated with dependency syndrome
Univariate analysis Multivariate analysis*
Odds ratio (95% CI) Odds ratio (95% CI)
p value Wald chi2 p value Wald chi2
Age at screening
Age 16-20 1 1
Age 21-25 1.65 (1.11-2.48) 0.014 2.45 1.76 (1.06-2.91) 0.03 2.21
Age 26-30 2.01 (1.25-3.23) 0.004 2.89 0.87 (0.45-1.69) 0.68 -0.41
Age 31-35 6.52 (3.43-12.39) < 0.001 5.72 1.16 (0.37-3.64) 0.79 0.26
Years of education
< 10 years 1 1
10-12 years 1.11(0.68-1.81) 0.68 0.41 0.91 (0.52-1.60) 0.75 -0.32
> 12 years 1.07 (0.63-1.81) 0.81 0.24 0.91 (0.50-1.67) 0.76 -0.30
Family history of substance use
Absent 1 1
Present 2.29 (1.57-3.37) < 0.001 4.26 2.36 (1.39-4.01) 0.002 3.16
Duration of use (years)
< 6 years 1 1
6-10 years 2.87 (1.90-4.33) < 0.001 5.02 3.62 (2.16-6.07) < 0.001 4.89
> 10 years 5.88 (2.91-11.91) < 0.001 4.92 7.18 (2.08-24.82) 0.002 3.12
Group
Areca only 1 1
Areca with tobacco additives 1.74 (1.18-2.56) 0.005 2.82 2.17 (1.39-3.40) 0.001 3.4
Smokers only 4.31 (2.76-6.73) < 0.001 6.44 7.87 (4.70-13.15) < 0.001 7.87
* Multivariate model included all the co-variates listed in the table
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cross-sectional design so our study was unable to
explore any time trends in use and the development of
dependency syndrome among areca nut users.
Public health implications
Pattern of areca nut use varies among different regions
as well as groups of population. Its use may lead to oral
diseases and malignancy, adverse pregnancy outcome
and systemic diseases as well [12]. Areca nut use poses
significant and avoidable morbidity and mortality. The
present findings suggest that areca nut with and without
tobacco additives is associated with dependence. Health
education and awareness are perhaps the most crucial
interventions required to be delivered so that the
adverse effects of the substance can be appreciated by
the community. Addressing a culturally sanctioned sub-
stance in terms of addiction and harm may meet with
considerable resistance, especially if attention resulted in
compromised supply or increased cost [12]. These inter-
ventions need to be focused on all age groups, in parti-
cular early age school children to avoid the future
morbidity and mortality associated with this substance.
Conclusions
Areca nut with and without tobacco additives is signifi-
cantly associated with the dependency syndrome. In
comparison to areca nut only users the smokers are
eight times more likely to develop dependence while
areca nut users with tobacco additives are also signifi-
cantly more likely to have the dependence.
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